Zit me te verdiepen in de ‘Digitale Omnibus’ van de Europese Commissie, een verbloemende term (ik denk aan een vrolijk jeugdboek) voor ‘versimpeling’ van bestaande regels waardoor onze digitale grondrechten afnemen en data bescherming en privacy verder onder druk komen. Moeten we niet willen. #SDBN
December 5, 2025 at 1:55 PM
Zit me te verdiepen in de ‘Digitale Omnibus’ van de Europese Commissie, een verbloemende term (ik denk aan een vrolijk jeugdboek) voor ‘versimpeling’ van bestaande regels waardoor onze digitale grondrechten afnemen en data bescherming en privacy verder onder druk komen. Moeten we niet willen. #SDBN
SDBN Trending: Cidara Therapeutics to Report Second Quarter 2025 Financial Results and Host Quarterly Conference Call on August 7, 2025 https://zpr.io/Xn3EDJhQCFdx
July 25, 2025 at 2:44 AM
SDBN Trending: Cidara Therapeutics to Report Second Quarter 2025 Financial Results and Host Quarterly Conference Call on August 7, 2025 https://zpr.io/Xn3EDJhQCFdx
SDBN Trending: Calidi Biotherapeutics Receives FDA Fast Track Designation for CLD-201 (SuperNova), a First-In-Class Stem-Cell Loaded Viral Therapy for the Treatment of Patients with Soft Tissue Sarcoma https://zpr.io/uQ5jPwtRkx7h
July 30, 2025 at 2:50 AM
SDBN Trending: Calidi Biotherapeutics Receives FDA Fast Track Designation for CLD-201 (SuperNova), a First-In-Class Stem-Cell Loaded Viral Therapy for the Treatment of Patients with Soft Tissue Sarcoma https://zpr.io/uQ5jPwtRkx7h
SDBN Trending: Wildfire Science & Technology Commons Opens to the Public to Unite and Accelerate Wildfire Solutions https://zpr.io/DkRA3kzaUWNP
July 29, 2025 at 2:49 PM
SDBN Trending: Wildfire Science & Technology Commons Opens to the Public to Unite and Accelerate Wildfire Solutions https://zpr.io/DkRA3kzaUWNP
SDBN Trending: Yatiri Bio Acquires NGeneBioAI to Expand AI-Powered Proteomics Platform and Advance Precision Biomarker Discovery https://zpr.io/ZfUiMzkXKi69
August 6, 2025 at 8:18 PM
SDBN Trending: Yatiri Bio Acquires NGeneBioAI to Expand AI-Powered Proteomics Platform and Advance Precision Biomarker Discovery https://zpr.io/ZfUiMzkXKi69
Thailand's Supreme Court orders the country's most powerful and polarising statesman Thaksin Shinawatra to be jailed for one year, ruling the former prime minister improperly served a 2023 prison term in hospital
u.afp.com/Sdbn
u.afp.com/Sdbn
September 9, 2025 at 5:19 AM
Thailand's Supreme Court orders the country's most powerful and polarising statesman Thaksin Shinawatra to be jailed for one year, ruling the former prime minister improperly served a 2023 prison term in hospital
u.afp.com/Sdbn
u.afp.com/Sdbn
SDBN Trending: ‘We’re Not a Line Item’—A Patient’s Plea to Protect Research Funding https://zpr.io/R62LTFd8Ju9Z
September 7, 2025 at 9:26 AM
SDBN Trending: ‘We’re Not a Line Item’—A Patient’s Plea to Protect Research Funding https://zpr.io/R62LTFd8Ju9Z
SDBN Trending: Perfect Balance Health Opens New Hormone Therapy Clinic in Hillcrest https://zpr.io/NzRHYVbi8N8k
August 29, 2025 at 9:11 PM
SDBN Trending: Perfect Balance Health Opens New Hormone Therapy Clinic in Hillcrest https://zpr.io/NzRHYVbi8N8k
SDBN Trending: $1.2M Award from the Keck Foundation Supports Innovative Study of Heart Attacks https://zpr.io/UbWiQJiwQ6pz
October 3, 2025 at 7:40 PM
SDBN Trending: $1.2M Award from the Keck Foundation Supports Innovative Study of Heart Attacks https://zpr.io/UbWiQJiwQ6pz
SDBN Trending: Why It’s Not Just About Money: Who Goes to the Ballet, Opera and Symphony https://zpr.io/3QebKhKEJyf4
October 23, 2025 at 9:48 PM
SDBN Trending: Why It’s Not Just About Money: Who Goes to the Ballet, Opera and Symphony https://zpr.io/3QebKhKEJyf4
SDBN Trending: How HIV’s shape-shifting protein reveals clues for smarter drug design https://zpr.io/fNGAFJFnQuGa
October 25, 2025 at 9:49 AM
SDBN Trending: How HIV’s shape-shifting protein reveals clues for smarter drug design https://zpr.io/fNGAFJFnQuGa
SDBN Trending: New Study Finds Strong Link Between Intimate Partner Violence and Firearm Ownership https://zpr.io/2rp6dGAu5WK5
December 4, 2025 at 12:08 AM
SDBN Trending: New Study Finds Strong Link Between Intimate Partner Violence and Firearm Ownership https://zpr.io/2rp6dGAu5WK5
SDBN Trending: Real Labs, Actual Decisions With Actionable Six Sigma Metrics https://zpr.io/Dwzemb9dAX5y
July 18, 2025 at 2:34 AM
SDBN Trending: Real Labs, Actual Decisions With Actionable Six Sigma Metrics https://zpr.io/Dwzemb9dAX5y
SDBN Trending: Belite Bio Reports Second Quarter 2025 Financial Results and Provides a Corporate Update https://zpr.io/z848MX3pLae7
August 11, 2025 at 8:26 PM
SDBN Trending: Belite Bio Reports Second Quarter 2025 Financial Results and Provides a Corporate Update https://zpr.io/z848MX3pLae7
SDBN Trending: ALCHEM? Celebrates Grand Opening of La Jolla Location Rebellious Health for Vibrant Living https://zpr.io/QAu5abzW4hb3
September 4, 2025 at 9:22 PM
SDBN Trending: ALCHEM? Celebrates Grand Opening of La Jolla Location Rebellious Health for Vibrant Living https://zpr.io/QAu5abzW4hb3
SDBN Trending: Cidara Therapeutics to Report Third Quarter 2025 Financial Results and Host Quarterly Conference Call on November 6, 2025 https://zpr.io/NMitCtmVCrMb
October 24, 2025 at 8:38 AM
SDBN Trending: Cidara Therapeutics to Report Third Quarter 2025 Financial Results and Host Quarterly Conference Call on November 6, 2025 https://zpr.io/NMitCtmVCrMb
SDBN Trending: Don’t Miss These 10 Fall ArtsConnect Events https://zpr.io/NUuRLyvZJyAk
October 15, 2025 at 3:59 AM
SDBN Trending: Don’t Miss These 10 Fall ArtsConnect Events https://zpr.io/NUuRLyvZJyAk
SDBN Trending: Bioinformatics Uncovers Regenerative Therapy for Spinal Cord Injury https://zpr.io/pYRcvN7ZuG57
October 30, 2025 at 5:28 AM
SDBN Trending: Bioinformatics Uncovers Regenerative Therapy for Spinal Cord Injury https://zpr.io/pYRcvN7ZuG57
SDBN Trending: UC San Diego’s Accelerating Innovation to Market Program Announces 2026 Cohort https://zpr.io/yvv2hV2cpqDV
December 7, 2025 at 3:13 AM
SDBN Trending: UC San Diego’s Accelerating Innovation to Market Program Announces 2026 Cohort https://zpr.io/yvv2hV2cpqDV
SDBN Trending: Thermo Fisher Receives FDA Approval for NGS-Based Companion Diagnostic for New Non-Small Cell Lung Cancer Treatment https://zpr.io/8Y5Mx95myfm8
August 12, 2025 at 8:27 AM
SDBN Trending: Thermo Fisher Receives FDA Approval for NGS-Based Companion Diagnostic for New Non-Small Cell Lung Cancer Treatment https://zpr.io/8Y5Mx95myfm8
SDBN Trending: Iambic Announces Research Collaboration with Jazz Pharmaceuticals for IAM1363 and Zanidatamab Combination Cohort in HER2-Positive Breast Cancer https://zpr.io/LVmYs9gJudnn
October 21, 2025 at 4:09 PM
SDBN Trending: Iambic Announces Research Collaboration with Jazz Pharmaceuticals for IAM1363 and Zanidatamab Combination Cohort in HER2-Positive Breast Cancer https://zpr.io/LVmYs9gJudnn
SDBN Trending: Belite Bio Announces Up to $275 Million Upsized Private Placement Financing by Leading Healthcare Investors https://zpr.io/H2bEX3ycbyQ9
September 8, 2025 at 9:27 PM
SDBN Trending: Belite Bio Announces Up to $275 Million Upsized Private Placement Financing by Leading Healthcare Investors https://zpr.io/H2bEX3ycbyQ9
SDBN Trending: Predicta Biosciences Secures $23.4M to Scale its Novel Diagnostic and Analytics Platform for Blood Cancers and Autoimmune Diseases https://zpr.io/SrJQ87akZGYP
October 2, 2025 at 1:40 PM
SDBN Trending: Predicta Biosciences Secures $23.4M to Scale its Novel Diagnostic and Analytics Platform for Blood Cancers and Autoimmune Diseases https://zpr.io/SrJQ87akZGYP
SDBN Trending: AltaSea Trustee Yehudi “Gaf” Gaffen to Receive Inaugural Gaffen Blue Champion Award at TMA BlueTech https://zpr.io/pZWptVbzW3CB
October 31, 2025 at 10:18 AM
SDBN Trending: AltaSea Trustee Yehudi “Gaf” Gaffen to Receive Inaugural Gaffen Blue Champion Award at TMA BlueTech https://zpr.io/pZWptVbzW3CB
SDBN Trending: Lawsuit DEADLINE: Investors who purchased over $100,000 worth of shares of Skye Bioscience, Inc. (NASDAQ: SKYE) between Nov. 2024 and Oct. 2025 should contact the Shareholders Foundation https://zpr.io/4sMEArz3KgSK
December 8, 2025 at 6:35 PM
SDBN Trending: Lawsuit DEADLINE: Investors who purchased over $100,000 worth of shares of Skye Bioscience, Inc. (NASDAQ: SKYE) between Nov. 2024 and Oct. 2025 should contact the Shareholders Foundation https://zpr.io/4sMEArz3KgSK